History of Zivolife

History of Zivolife

1933: Entrepreneurs notice a low incidence of arthritis and other autoimmune diseases in the villages surrounding an alpine lake in Germany and decide to collect the local water.
1945-1980: The water from the alpine lake is transported to the United States and cultivated. This water sample, considered a polyculture containing various aquatic species such as algae, fungi, and microorganisms, becomes the basis for a home remedy known as Lebenszeit, which translates to "lifetime" in English. Once the microorganisms are strained and removed, Lebenszeit is consumed as a drink.
1980-2003: Lebenszeit is commercialized and marketed as ProAlgaZyme. While cultivation methods are refined and standardized during this period, the product remains small-scale, and quality control proves challenging. ProAlgaZyme continues to be sold as a concentrated liquid, with the microorganisms from the polyculture removed.
2003-2016: Zivo Bioscience, Inc. (ZIVO) acquires the technology and embarks on scientific research to elucidate the product's specific health benefits and substantiate health claims through studies in both humans and animals. Research supports the benefits of ProAlgaZyme in cardiovascular health, autoimmune disorders, inflammation, weight loss, and disease recovery.
2016-2023: Through extensive research, Zivo Bioscience identifies Klebsormidium as the key bioactive organism and subsequently isolates, registers, and develops cultivation methods for Klebsormidium flaccidum var ZL01, also known as Zivolife. ZIVO continues to expand its understanding of the culture and health benefits through scientific studies and patents utilizing biomass from Klebsormidium flaccidum var ZL01.
ZIVO secures patents in the United States and internationally, covering the production and application of Klebsormidium biomass as a remedy for immunological and other health issues in both humans and livestock animals.
Back to blog